Sign in
Controlling Uveitic Recurrences: Results From a Phase 3 Study of 0.18 mg Fluocinolone Acetonide Insert (FAi) in Noninfectious Posterior Uveitis
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2018
Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
Antimicrobial Injection Frequency in the Management of Presumed Bacterial Endophthalmitis: An International Survey of Retina Specialists
Colin A. McCannel, MD
Category: Diabetic Retinopathy